Vevye plus Flarex eye drops for moderate to severe dry eye
Treatments studied
Part of Eyes & vision clinical trials.
This study tests a combination of two eye drop medications (Vevye and Flarex) to see if they work better together for treating moderate to severe dry eye. If you have persistent dry eye that hasn't improved with other treatments, this trial might help you and advance treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have moderate to severe dry eye symptoms (scored 30 or higher on a standard pain scale)
- Not be pregnant or breastfeeding (if you could become pregnant, you must use reliable birth control)
- Not have had eye surgery or serious eye injury in the past 12 months
- Not have uncontrolled health conditions like diabetes or high blood pressure
- Not currently take systemic medications known to worsen dry eye, such as certain antihistamines or antidepressants
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks whether VEVYE®, a prescription eye drop, reduces dry eye symptoms and signs in people who have both a neuro-ophthalmic condition (a nerve or brain issue affecting the eyes) and dry eye disease. You'll visit the clinic for 6 months and answer questions about your eye comfort.
This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.
This study tests a new eye drop called TRYPTYR to see if it can improve quality of life and daily tasks for people with dry eye disease who are unhappy with their current treatment, Restasis. Participants will stop using Restasis and switch to TRYPTYR for about 4 weeks.
This study tests two types of preservative-free eye drops to see which is more effective for people with mild to moderate dry eye disease. You will use one of the drops as directed, and the study will monitor your symptoms and eye health over time.
This study compares two different cyclosporine eye drops to see which one better improves the health of the surface of your eye. One is a newer version (Vevye) and the other is a generic version of Restasis, over 8 weeks of treatment.
This study tests if Vevye eye drops can improve symptoms of meibomian gland dysfunction, a condition where the tiny oil glands in your eyelids get blocked. It may help reduce dryness and discomfort.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.